RxDoctor Payments DataLook up a doctor →

GABLOFEN 1 mL in 1 SYRINGE, GLASS: payments to doctors

Payments that named GABLOFEN 1 mL in 1 SYRINGE, GLASS as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$38K
Providers
178
Transactions
332
Average per transaction
$114

The per-transaction average — $114 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 178 providers the average total is $213, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Piramal Critical Care$37,935100.0%
← All drugs & devices